✦ LIBER ✦

PCN32 COST-UTILITY ANALYSIS OF DOCETAXEL VERSUS OTHER REGIMENS IN THE NEOADJUVANT THERAPY OF LOCALLY ADVANCED BREAST CANCER IN POLAND

✍ Scribed by J Walczak; D Pawlik; R Wojcik; M Kaczor; J Lis; G Nogas

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN13 COST-EFFECTIVENESS ANALYSIS OF DOC

✍ J Walczak; D Pawlik; R Wojcik; M Kaczor; J Lis; G Nogas 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB

PCN38 COST-EFFECTIVENES ANALYSIS OF DOCE

✍ J Walczak; K Lasota; I Malczak; D Pawlik; A Semeniuk; A Simon; M Bryl; J Lis; G 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB

Cost-utility analysis for advanced breas

✍ Michael Patrick Lux; M. Hartmann; C. Jackisch; G. Raab; A. Schneeweiß; K. Possin 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 849 KB

PCN3: COMPARISON OF COSTS AND EFFECTS OF

✍ E Orlewska 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

PCN35 A COST UTILITY ANALYSIS OF FULVEST

✍ M Pangali; A Christodoulopoulou; A Ardavanis; V Barbounis; E Galani; D Skarlos 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB

PCN92 COST-EFECTIVENESS ANALYSIS OF DOCE

✍ C Tenorio; J Vargas; J Martínez; Á Paladio 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB